Clinical trial

Tiotropium + Procaterol vs Tiotropium + Placebo in COPD Patients

NCT00394485 · Otsuka Pharmaceutical, Inc., Philippines, Industry · Terminated

Key facts

NCT number NCT00394485
Title Tiotropium + Procaterol vs Tiotropium + Placebo in COPD Patients
Official title A Randomized Crossover Trial Comparing the Efficacy and Safety of Tiotropium + Procaterol vs. Tiotropium + Placebo in Moderate COPD Patients
Lead sponsor Otsuka Pharmaceutical, Inc., Philippines, Industry
Collaborators Otsuka Pharmaceutical Co., Ltd. Industry
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Pulmonary Disease, Chronic Obstructive
Intervention type Drug
Interventions Procaterol, Tiotropium
Enrollment 50
Start date May 1, 2006
Completion Apr 1, 2008
First posted Nov 1, 2006
Last update posted Dec 17, 2009
Countries Philippines

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies